---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-012454"
form_type: "8-K"
ticker: "CYDY"
cik: "0001175680"
company_name: "CytoDyn Inc."
filed_at: "2022-08-05T23:59:59+00:00"
generated_at: "2026-06-24T03:12:14.546262+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# CytoDyn restates FY2021 and five quarterly periods; prior financials no longer reliable

## Summary
- Audit Committee concludes FY2021 annual and five quarterly periods should not be relied upon.
- Error: convertible note settlements accounted as extinguishments instead of induced conversions.
- Restatement changes non-cash loss on debt settlement, APIC, accumulated deficit, and net loss.
- Estimated understatement of net loss ranges from $2.6M to $24.3M across affected periods.
- Material weakness in internal control over financial reporting identified for 2020-2021 periods.

## SEC filing metadata
- accession: 0001558370-22-012454
- form_type: 8-K
- ticker: CYDY
- cik: 0001175680
- company_name: CytoDyn Inc.
- filed_at: 2022-08-05T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 4.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175680/000155837022012454/0001558370-22-012454-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175680/000155837022012454/cydy-20220804x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-012454
- JSON: https://secwatch.observer/filing/0001558370-22-012454.json
- Plain text: https://secwatch.observer/filing/0001558370-22-012454.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.